Building the commercial case for a University of Strathclyde metal recovery technology

An ongoing Commercial Champion engagement with the University of Strathclyde. The work has moved a wastewater metal recovery technology through a staged public commercialisation pathway from qualification, into company creation funding, and toward spinout with a service-revenue business model and an industrial validation pipeline that will position the venture for seed funding.

The starting position

The technology arrived with strong underlying chemistry and the commercial shape most university IP carries at the start. A patented sorbent-based metal recovery process developed at the University of Strathclyde had been validated at laboratory scale, with metal recovery loadings an order of magnitude greater than competing technologies and a patent through PCT stage. The chemistry was good.

What was less clear was everything downstream of the science. Which industrial market should be pursued first, plating, mining wastewater, or battery recycling? What business model would turn a chemistry advantage into a fundable company with unit sales, licensing, or recurring-revenue service? Which industry players would provide the validation strong enough to credential the venture for investors? And how would the project move, deliberately and defensibly, from a research-grade demonstrator to a spinout attracting seed investment?

The University had recognised the commercial potential and qualified the project for a structured public commercialisation pathway with sequential funding gates. The commercial case to move it through those gates did not yet exist in fundable form.

What we did

The engagement was structured around the staged commercialisation pathway. Hatch’s role began as Commercial Champion during the qualification phase the structured commercial screen used to assess which university technologies warrant further public investment from Scottish Enterprise Council and has continued through selection for company creation funding and into pre-spinout preparation. From the outset the work was not a periodic advisory input but a continuous commercial partnership embedded in the venture’s decision-making.

Qualification phase

Commercial Champion work in this phase centred on answering the questions the funding pathway needed to see answered before recommending the project for company creation. Hatch took over from another company that had screened candidate applications against commercial pull, technical fit, and time-to-deployment. We ran market sizing across the three candidate industrial segments and introduced a beachhead in plating, with mining wastewater as a longer goal. And we built the early industry validation pipeline through structured outreach, with repeat engagement secured from tier-one operators in each candidate segment.

The outcome was a named beachhead. Industrial plating and circuit-board manufacture was selected against mining on the strength of shorter deployment timelines, accessible unit economics relative to incumbent treatment routes, and a defined addressable spend across hundreds of UK and European sites. Mining wastewater remediation was positioned as a high-value secondary market with longer validation cycles that would not suit the venture’s first phase but would re-emerge once the beachhead was established.

Company creation preparation

With the beachhead defined and industry validation in hand, the engagement moved into full pre-spinout development. Work across this phase has included the service-revenue business model with multiple named revenue streams and gross margin projections for both services and unit sales; a four-stage phased capital plan from company creation through seed, Series A, and global scale-up; the investor pipeline across clean-tech and industrial-tech funds, with pitches delivered to or arranged with several. The engineering design of the modular treatment unit, developed by Chris Gregory, Hatch Oxford’s Co-Founder.

The venture was selected for public company creation funding with confirmed University in-kind support. A further co-investment raise is now in progress to complete industrial pilots, submit the regulatory dossier, finalise the exclusive IP licence from the University, and form the spinout.

The commercial move

The most consequential single commercial decision in the engagement was the selection of a service-revenue business model not just unit sales as the venture’s primary commercial structure. The default for a deep-tech hardware venture is to sell the product. Customers buy a treatment unit; the venture recognises revenue at sale. The service-revenue model inverts that. Customers pay per cubic metre of wastewater treated, or per kilogram of metal recovered. The venture retains ownership of the unit, captures recurring revenue, and keeps economic exposure to the recovered metal itself. Unit sales and licensing remain in the business model, but as adjacent revenue streams rather than the primary one.

Three consequences follow from that choice. The venture’s revenue becomes recurring and predictable, which makes it materially easier to finance. The economic incentives between venture and customer align both benefit when more metal is recovered. And the venture retains exposure to upside in metal prices, not just in treatment volume.

For a technology whose fundamental advantage is throughput per unit mass of active material, the service-revenue model is the model that matches the engineering reality. Designing the model that way from the outset rather than defaulting to unit sales and discovering later that it has mispriced the venture is a material piece of commercial work in its own right. It is the kind of work that pays for itself many times over once the venture reaches investor conversations.

Why it matters

The engagement illustrates what structured commercialisation looks like when the commercial work is embedded in the funding pathway rather than bolted onto it. Staged public pathways qualification, then company creation, then spinout and seed give a university technology the benefit of defined decision points and sequential funding gates. The pathway only works, however, when the commercial case is being developed continuously alongside the science, not assembled late for each funding deadline.

Too many university projects treat each stage of the pathway as a separate exercise: a new application, written by a new consultant, from scratch. The technologies that move through the stages most efficiently are those where one team holds responsibility for the commercial case the entire way sharpening it at each stage rather than rebuilding it. That continuity is often the difference between a promising project and a company that actually forms.

A note on status

The venture has been selected for public company creation funding and is currently raising co-investment. It is on track to form as a spinout in 2027, with industrial pilots and the next technology readiness milestone ahead within the next eighteen months. This case study describes the commercialisation work that has positioned the venture for those milestones; it does not claim outcomes the venture has not yet reached. Specific industrial counterparties, named investors, and detailed deal postures remain commercially confidential.

Three pathways commercialising process IP for a high-volume materials sector

A commercial viability assessment commissioned by a UK university enterprise office. The strategy reframed the commercialisation question from single spinout to three pathways in parallel and identified manufacturing scrap, not end-of-life feedstock, as the fastest route to commercial traction.

The starting position

A UK university enterprise office approached the engagement with a process technology that had reached strong technical performance in the lab. The IP demonstrated reproducible separation across multiple feedstock variants and across the chemistries that dominate the application sector. Benchmark data showed near-complete separation efficiency at an order of magnitude lower energy than the incumbent chemical and thermal routes, and at a cost per tonne that compared favourably with the incumbent mechanical alternatives. The technology was credibly differentiated.

What the University did not yet have was a defensible commercial articulation. The application sector is a crowded narrative. Large-scale chemical processing players dominate the public conversation. Adjacent direct-recovery routes are emerging but unproven at scale. Equipment manufacturers are increasingly bundled into turnkey contracts that take years to break into. 

The University needed an external commercial assessment: a market view built from the bottom up, a competitive landscape mapped against where the technology actually competes, and a recommendation on commercial form that respected the technology’s structural strengths rather than the institutional default.

What we did

The engagement was scoped and contracted as a paid commercial viability and market engagement assessment, conducted in collaboration with the academic lead on the underlying research programme. The work was anchored on three connected questions: how large is the addressable market, where does the technology sit against the competition, and what commercial form will move fastest into revenue.

Bottom-up market modelling. We built the market model from the production end of the value chain inwards, starting from the manufacturing capacity that the application sector already operates and is committed to expanding. From there we sized the total addressable market across the broader recovery sector, the serviceable addressable market for the segments where the technology’s strengths apply directly, and the serviceable obtainable market on early-stage adoption assumptions. A separate equipment-integration track, modelled against capital-equipment budgets in the application sector, contributed a further serviceable opportunity. The two together established the portfolio-scale commercial opportunity.

Commercialisation pathway analysis. Rather than recommend a single commercial form, we tested three in parallel: process licensing to existing operators, direct sale of modular equipment through established line integrators, and joint ventures with producers running high-scrap-rate ramp operations. For each pathway we set out adopter readiness, deal-size expectations, technical integration demands, and the conditions under which each pathway outperforms the others.

Regulatory and sustainability framing. We anchored the commercial narrative in the regulatory pull. Sustainability and critical-materials policy in both the EU and US is moving toward compliance regimes that reward low-energy, low-solvent, traceability-friendly processing — exactly the conditions that favour the technology. The regulatory framing identified the EU and US as the commercially receptive first-beachhead markets and informed the geographic prioritisation in the pathway recommendation.

The commercial move

The first reframe was the priority feedstock. The public narrative for this application sector is dominated by end-of-life material the volumes projected to arrive in the late 2020s and 2030s as installed assets reach the end of their service life. Those volumes will eventually be the largest market. They are not the market that generates the first commercial contract. Manufacturing scrap is generated continuously inside production facilities, co-located with the production equipment, homogeneous in composition per line, and known-chemistry a feedstock profile that is cleaner to process than the mixed-composition end-of-life streams the public conversation is built around. For a process whose structural advantage is purity and binder-agnostic separation, the manufacturing-scrap stream is the one that rewards the technology’s strengths most directly. End-of-life remains a valid long-term market. It is not the market that generates first revenue.

The second reframe was the commercial form. A single-spinout posture would force the technology to compete on terms that do not match its strengths. The technology is enabling process IP. Its natural commercial form is enabling-IP commercialisation: licensed into operators who already have the customer relationships and the scale, sold as modular equipment by integrators who already have the procurement frameworks, and joint-ventured with producers whose internal scrap economics make co-development the right deal structure. None of these forms is the right answer alone.

What the engagement produced

• A bottom-up market model with defensible total, serviceable, and obtainable market figures, plus a separate equipment-integration track with its own serviceable opportunity sized against capital-equipment budgets.
• A competitive benchmarking matrix comparing the technology against incumbent chemical, thermal, and mechanical routes on cost, energy, purity, and carbon footprint.
• A four-segment adopter map covering incumbent processors, direct-recovery operators, capital-equipment manufacturers, and producers with internal scrap operations — with the entry point identified per segment.
• Three commercialisation pathways evaluated in parallel — process licensing, equipment supply, and joint venture — with adopter readiness, deal-size expectations, and integration demand for each.
• A regulatory-pull narrative anchored in EU and US sustainability and critical-materials policy, with first-beachhead geographic prioritisation.
• A risk register covering industrial conservatism, line integration, process safety, feedstock format variability, contamination, regulatory compliance, IP and freedom-to-operate, and scale-up.
• A recommendation against single-spinout framing, in favour of an enabling-IP posture that supports licensing, equipment supply, and JV routes concurrently — with manufacturing scrap identified as the fastest revenue feedstock ahead of end-of-life material.

Why it matters

The general-purpose observation is that the institutional default a new spinout is not always the right commercial form for enabling process IP that sits upstream of a mature industrial value chain.

University technology programmes routinely face a narrative forced on them before the evidence justifies it. Spinouts are visible, fundable, and celebrated. They are also slow to revenue, expensive to capitalise, and structurally mismatched to enabling IP whose value lies in being adopted into other people’s products and processes rather than in carrying a standalone company. The more honest answer that the technology should enter the market as enabling IP, through multiple commercial forms in parallel, against the feedstock that pays first is the harder answer to arrive at without grounded market work.

The broader point is structural. In sectors where industrial volumes are growing fast and the public narrative focuses on the end-of-life half of the value chain, the economics that fund the next decade of infrastructure build-out are often being generated now, on the production side, by waste streams that grow with manufacturing capacity rather than with installed asset retirement. Technologies that can attach themselves to that cash flow — without waiting for end-of-life volumes to arrive — have a measurable commercial advantage. That observation is not unique to one engagement. It is the observation any commercialisation case for an enabling process technology should be built around.

A note on status

The engagement is complete and the strategy is delivered. The commercialisation recommendations are with the University for execution. Specific adopter engagements, deal postures, and counterparty detail remain commercially confidential. This case study describes Hatch Oxford’s methodology at the level it can be discussed publicly. The client, the technology, the application sector, the specific findings, and any counterparties are not identified.

Two technologies, two commercial forms — a strategy review for one research group

A commercial strategy review commissioned by a UK university research group with two adjacent thermal-energy technologies. The review delivered separate commercialisation pathways — spinout for the standalone technology, licensing or integration for the subsystem — and the analytical framework that distinguished the two.

The starting position

A UK university research group approached the engagement with two technologies developed in parallel by the same lead researcher. Both addressed adjacent problems in thermal energy management. Both had reached a credible technical readiness level. Both had a plausible commercial future. The research group needed to know how to commercialise them.

The institutional instinct, faced with two credible technologies from one group, is to commercialise them together — usually as the joint IP base of a single new spinout. That instinct has obvious appeal: it concentrates value, it tells one story to investors, and it lets a single founding team carry both pieces of work. But it is rarely the right answer. Adjacent technologies can have radically different commercial forms even when their technical roots are shared, and choosing the wrong form for either is the kind of mistake that wastes years of research investment.

What the research group needed was an external commercial assessment of both technologies on the same terms — to surface the commercial profile of each on its own merits, and to recommend the form, route, and sequencing for each independently.

What we did

The engagement was scoped and contracted as a paid commercial strategy review across both technologies. The work was anchored on three connected questions for each technology: what commercial form fits, what is the route to market, and what is the realistic technical roadmap to deployment readiness.

Technology and value-proposition assessment. We characterised each technology against the same framework — what it is, what it solves, where it differentiates, and what its technical readiness level is against the development roadmap that would take it to deployment. The two technologies looked similar at a research-group level. Assessed against the framework, they diverged immediately.

Market analysis across two adjacent sectors. The two technologies sat in adjacent but distinct industrial sectors with overlapping customers, different procurement cycles, different regulatory drivers, and different competitive landscapes. We analysed both sectors separately and made the differences explicit — what looked like a single market opportunity at the research-group level was two markets when assessed commercially.

Competitive landscape mapping. We identified the credible incumbents in each adjacent product category and mapped how each technology positioned against them. The standalone technology had clear differentiation against the named incumbents. The subsystem technology sat alongside, not against, the equivalent incumbents — it was an enhancement to their products rather than a replacement for them. That distinction shaped the commercial form recommendation directly.

Technical roadmap and gap analysis for each. We produced a development roadmap and gap analysis for each technology separately, with the work-package structure and partnership requirements that would close the gaps in each case. The technologies sat at different TRLs and required different development sequencing — they could not be advanced together on a single roadmap.

Commercialisation route options. For each technology, we set out the commercialisation route options — spinout, licensing, joint venture, integration with an established partner — and recommended the form best fitted to that technology’s profile. Then we set out the relationship between the two recommendations, since the research group would need to execute both pathways in coordination if they were going to do justice to either.

The commercial move

The most consequential analytical move in the engagement was the recognition that the two technologies, despite their shared technical roots, were not the same kind of commercial proposition.

The standalone technology was a product. It could be sold as a discrete unit. It could be specified, certified, and deployed without a host system. It had clear differentiation against named incumbents in its product category. Its market — multiple adjacent applications across residential, commercial, and industrial settings — was broad enough to support a focused spinout with multiple licensing routes downstream. The recommendation for this technology was a dedicated spinout, with the IP held by the new company and licensing as a secondary revenue stream.

The subsystem technology was a feature. It enhanced the performance of an existing class of equipment but could not be sold to end-users on its own — adoption required integration into a host system manufactured by an established player. The market was narrower, dominated by a small number of incumbent equipment manufacturers, and the commercial unit of value was a license or co-development agreement with one of those incumbents rather than a direct sale to an end-user. The recommendation for this technology was licensing or integration with an established player, not a separate spinout.

Two consequences follow from that pair of recommendations.

Trying to build two spinouts where the evidence supports one is the most expensive form of optimism in deep-tech commercialisation. It splits the founding team’s attention, raises the cost of fundraising, and leaves the weaker of the two propositions absorbing capital that should be going into the stronger. The discipline is to recognise — early — which technology can carry a company and which technology should be commercialised through someone else’s.

The two pathways need to be coordinated. The subsystem technology’s licensing programme will produce conversations with established equipment manufacturers — and those manufacturers are exactly the partner ecosystem the standalone-technology spinout will eventually need for its industrial-application licensing. Sequenced well, the subsystem licensing work becomes the relationship-building substrate for the spinout’s downstream licensing programme, and the value of doing both engagements together compounds.

What the engagement produced

• A parallel technology and value-proposition assessment for both technologies, against a common analytical framework.
• A market analysis covering both adjacent industrial sectors, with the differences in procurement cycle, regulatory driver, and competitive landscape made explicit.
• A competitive landscape mapping for each technology, with named incumbents in each adjacent product category and the positioning of each technology against them.
• Technical roadmaps and gap analyses for each technology — separately structured, since the two could not be developed together on a single roadmap.
• Commercialisation route options for each technology, with a specific form recommended for each: a dedicated spinout for the standalone technology, licensing or integration with an established partner for the subsystem technology.
• A coordination framework specifying how the two pathways should be sequenced — so that the subsystem licensing programme builds the relationships the spinout will eventually need for its downstream licensing.
• A risk register covering both technical and commercial risks for each technology, with mitigation framing.
• A future development plan with funding routes mapped to the development stage of each technology.

Why it matters

The general-purpose observation is that adjacent technical roots can produce radically different commercial outcomes.

Research groups are typically more confident about the science underpinning their work than about the commercial form their work should take. That is the right way round — research groups are not commercialisation specialists, and they should not be expected to be. But it means that the question of commercial form, when it is finally asked, is often answered by institutional reflex rather than by analysis. The reflex with two adjacent technologies is to commercialise them together. The reflex is wrong often enough that asking the question with discipline pays for itself many times over.

The discipline is recognising which of two credible technologies is a product, which is a feature, and treating each accordingly. A product can carry a spinout. A feature cannot — it has to be commercialised through someone else’s product. Confusing the two is one of the most common failure modes in early-stage deep-tech commercialisation, and it is a failure mode that has nothing to do with the underlying science being good or not. The science is usually fine. The commercial form is what gets it wrong.

For a research group with credible IP in adjacent areas, the work of distinguishing product from feature is not optional. It is the gating analytical step before any commercialisation pathway can be confidently chosen.

A note on status

The engagement is complete and the strategy review is delivered. Subsequent commercialisation activity remains commercially confidential. This case study describes Hatch Oxford’s methodology at the level it can be discussed publicly. The client, the technologies, the application sectors, the specific findings, and any counterparties are not identified.

Spin-out commercialisation strategy for a university robotics research programme

A two-phase commercialisation engagement commissioned by a UK university enterprise office. Phase 1 produced the commercial form recommendation and spin-out readiness gap analysis; Phase 2 — spin-out formation and readiness — is now live.

The starting position

A UK university enterprise office approached the engagement with a research programme that had reached a familiar inflection point. A novel industrial robotics technology aimed at an emerging circular-economy application had been developed through a sequence of national research grants. A working prototype existed. The underlying capability was real. What did not yet exist was a defensible commercial articulation of what a company built around the prototype would actually be — who it would sell to first, what commercial form it should take, and what gaps stood between a research-grade demonstrator and a fundable spin-out.

The application sits in a market that almost every observer agrees is coming, but almost no-one has built. The industry’s default answer to the underlying problem is conservative: an existing process that is technically and economically simpler than the alternative, but which destroys downstream value. The research programme’s thesis is that purpose-built robotics — combining application-specific software, vision-assisted operation, specialised tooling, and rigorous safety procedures — can replace the default with a process that preserves value rather than destroying it.

What the University needed was an external commercial assessment: not a technical review, but a structured view of whether, where, and on what terms a company built around the prototype could credibly trade.

What we did

The engagement was scoped and contracted as a paid commercial viability and spin-out readiness assessment, delivered as Phase 1 of a two-phase programme. Phase 1 was a three-month fixed-fee engagement anchored on four explicit questions: the unique selling proposition and commercialisation barriers, the best commercial form (licensing, joint venture, or spin-out), the readiness state of the programme if a spin-out were recommended, and the business model and how to test it.

Technology and market structuring. We characterised the technology stack across five layers — software (planning, AI, human-machine interface), hardware tooling, application-specific testing and safety, integration and system design services, and a licensing-and-royalty line across all of these. For each layer we mapped what the University currently held, where the prototype sat against it, and what additional development was required to reach deployment readiness. That structuring was the precondition for every downstream commercial question.

Adopter segmentation and primary research. We identified six candidate adopter segments and conducted primary interviews across each. Each segment was ranked on adoption timescale, decision drivers, budget availability, regulatory exposure, and risk factors. The fastest-moving segment emerged at twelve to eighteen months — driven by stock availability, the desire to scale quickly, and operational pressures the existing default process did not address. Adjacent segments followed at eighteen to twenty-four months. The slowest segments — automotive-tier procurement chains — sat at thirty-six to forty-eight months. The segmentation made explicit what the engagement needed to make explicit: chasing the slowest, most-procurement-bound segment first would consume the spin-out’s runway before it reached revenue.

Competitive landscape. We mapped the competitive landscape across three tiers: research-grade programmes in adjacent application areas, private-sector operators in different application segments, and tier-one industrial robot manufacturers. The central observation was that the industry perception of capability ran ahead of the industry reality. Many companies claim adjacent capability; few have demonstrated commercial penetration into the target application; no dominant competitor occupies the space.

Commercial form recommendation. The recommendation was to form a spin-out, positioned as a systems integrator rather than a hardware manufacturer or a pure research-licensing vehicle. The integrator positioning treats robot manufacturers as suppliers, not competitors. It sits on the narrow slice of IP where the programme is defensibly differentiated — the application-specific software, the application-specific testing, and the tooling know-how. And it lets the business generate revenue through design-and-build contracts, with each customer project compounding the software’s learned library, the testing procedures’ validated envelope, and the tooling catalogue.

Business model and gap analysis. We specified the business model (a systems-integrator line with licensing overlay), the technical roadmap from prototype to TRL 8–9 with explicit work-package structure, a funding map across grants, partnerships, investment, and customer contracts, and the gap analysis the spin-out would need to close before first customer sale. Named candidate partners were identified across the relevant ecosystem categories — those conversations are the substance of Phase 2.

The commercial move

The central move was the choice of commercial form and beachhead: a systems-integrator spin-out — not a hardware manufacturer, not a pure research-licensing vehicle — with the fastest-moving adopter segment as the first customer base.

That pair of choices does specific work.

The systems-integrator positioning takes the three things the research programme had genuinely produced — application-specific software, application-specific testing capability, and the tooling know-how to make both work in production — and packages them in a form where they compound. Every customer project extends the same library, the same validated procedures, the same tooling catalogue. A hardware-manufacturer positioning would not do that. It would force the spin-out into hardware-economics competition against companies with an eight-figure R&D budget lead.

The beachhead choice — the fastest-moving segment first — buys the spin-out an adopter group with the shortest procurement cycle, the highest stock availability, the clearest operational motivation, and no credible UK competitor. That is the combination that gives a spin-out eighteen months of runway to reach first commercial revenue rather than three years. For a deep-tech spin-out, that difference is frequently the difference between Series A and fold.

The alternative path — the natural one a research team’s instinct will reach for — is to chase the largest, most prestigious end-customer first. In this market, that meant the segment whose procurement cycles run thirty-six to forty-eight months. The engagement’s most useful service to the research team was naming clearly that the prestige path is the path that runs out of cash before it reaches revenue.

What the engagement produced

• A five-layer technology structuring of the research programme’s capability stack — software, hardware tooling, application-specific testing, integration services, and a licensing-and-royalty layer.
• A six-segment adopter map with ranked adoption timescales from twelve to eighteen months at the fastest end to thirty-six to forty-eight months at the slowest.
• A three-tier competitive landscape map across research-grade programmes, private-sector operators, and tier-one industrial robot manufacturers.
• A primary-research programme across all six adopter segments, with documented decision drivers, budget profiles, and risk factors per segment.
• A value-proposition articulation across five dimensions — economic, environmental, operational, regulatory, technological — segmented by target market.
• A commercial form recommendation: spin-out as systems integrator, with licensing overlay.
• A beachhead recommendation: fastest-moving adopter segment first, adjacent segments second, the most procurement-bound segments deferred.
• A technical roadmap from prototype to TRL 8–9 with work-package structure and test plan.
• A funding map across grants, partnerships, investment categories, and customer contracts.
• A gap analysis identifying the priority closures before first customer sale — software, tooling, safety certification, application-scale trials, and real-world testing.
• A named candidate partner list across the relevant ecosystem categories — the basis for Phase 2 partnership conversations.
• A business-goals framework with milestones for spin-out formation, certification, first customer purchase order, and brand exposure.

Why it matters

The general-purpose observation is that the defensible slice of a research programme is rarely the same as the deployable slice.

A research programme’s underlying technology can almost always be deployed across many adjacent applications. But the defensible slice — the slice where the IP genuinely differentiates and where competing cannot be done just by buying hardware — is usually narrow. Venture-building on the deployable slice produces a contract shop that competes on price and cannot sustain IP-based valuation. Venture-building on the defensible slice produces a business that compounds with every customer project. Distinguishing the two is the central analytical act of spin-out commercialisation work.

The broader point about this specific market is that it is structurally open. Industry perception runs ahead of industry reality. No dominant competitor holds the space. The regulatory and sustainability environment is pulling volumes toward the new process faster than the industry’s current default answer can absorb. A credibly scoped spin-out with a defensible business model and a well-chosen beachhead is well-placed to be the first to occupy that space.

For a research team holding a credible technology and an MVP, that is the analytical work that converts research IP into a fundable spin-out. The technology is rarely the limiting factor. The commercial articulation is.

A note on status

Phase 1 — the commercialisation strategy assessment — is complete and delivered. Phase 2 — spin-out formation and readiness — is now live. The engagement and its findings remain commercially confidential. This case study describes Hatch Oxford’s methodology at the level it can be discussed publicly. The client, the technology, the application sector, the specific findings, and any counterparties are not identified.

Airplus Renewables — XEVA — from prototype to certification, an engineering partnership with a rooftop vertical-axis wind platform

An ongoing commercial engineering partnership running the XEVA programme from prototype through certification. Generator selection, baseline CFD, iterative aerodynamic optimisation across rooftop typologies, wind-tunnel validation, and a mounting-system engineering conclusion that has shaped the product architecture itself.

The starting position

Small-scale rooftop wind has a reputation problem. The market has been shaped by a first generation of products that over-promised on siting flexibility, underperformed against marketing-case annual energy yields, and in many cases failed to reach certification at all. The underlying physics is the explanation. Wind flow over a building is not the wind flow over open terrain. Structures force the incoming wind to accelerate at the windward wall, separate at the roof edge, form a recirculation bubble over the central roof area, and re-attach downstream with elevated turbulence intensity.

A turbine placed a few metres away from its designed-for position can move from an acceleration zone into a dead zone. Turbulence increases vibration and fatigue loading and shortens service life. Power in the airstream scales with the cube of wind speed, so modest siting errors translate into large energy shortfalls. The underlying building aerodynamics are unpredictable from first principles — parapets, HVAC plant, neighbouring buildings, and roof edge geometry all alter the flow field in ways that empirical siting rules cannot fully capture.

Airplus’s product thesis is that the answer is an engineered system, not an off-the-shelf turbine bolted to a roof. XEVA’s design intent integrates the turbine aerodynamics, a tolerant multi-directional intake geometry, a mounting that permits post-install repositioning as actual on-site wind patterns become clear, and onboard storage and smoothing so the deliverable power profile is shaped to the host site’s demand rather than the raw instantaneous generation. Delivering that thesis requires an engineering programme with depth — not just a turbine design, but a siting, mounting, and power-conditioning system engineered against verified building-flow physics.

What we did

Hatch Oxford was engaged in May 2024 as the engineering partner for the XEVA programme, under a multi-year consultancy framework with work packages agreed sequentially against the product roadmap.

Phase 1 — Prototype and generator selection

We began with the generator. The Airplus base-model prototype specification needed a generator matched to the turbine’s rotor characteristics, expected operating envelope, and the power-conditioning architecture downstream. We ran the selection against the technical specification and delivered a generator choice that conformed to the prototype requirements — the first commitment in the engineering programme and the foundation on which the later aerodynamic and power-profile work would be built.

Phase 2 — Baseline CFD

Immediately after generator selection we commissioned the baseline CFD model for the base-model turbine, working through an agreed specialist sub-contractor. Baseline CFD is the entry condition for any serious rooftop wind programme — without a defensible CFD view of how the turbine interacts with characteristic building-flow regimes, there is no basis for rotor refinement, intake geometry development, or siting guidance. The baseline model established the flow fields in which the turbine would be expected to operate and the aerodynamic boundary conditions the rotor would need to perform against.

Phase 3 — CFD iteration and wind-tunnel validation

From the baseline we moved into iterative aerodynamic development. Building-flow scenarios were characterised across the representative host-site typologies — long flat-roof warehouse and industrial buildings, multi-level hospital and commercial roofs with HVAC plant and parapet disturbance, and dense urban settings with street-canyon vortex behaviour. For each typology, CFD was used to identify where on a given roof the turbine would see productive flow versus where it would sit in a recirculation bubble or a high-turbulence wake.

We then took the prototype into wind-tunnel testing to validate the CFD predictions against physical measurement. The combined CFD-plus-tunnel dataset has driven design iterations on the rotor, the intake geometry, and — importantly — the mounting system, where the emergent engineering conclusion was that post-install repositioning capability is a product requirement rather than a nice-to-have. Empirical siting rules are not sufficiently predictive for every real-world rooftop. The product needs to accommodate adjustment once the installed behaviour is observed — and that is a mechanical and mounting-system decision, not a software one.

Phase 4 — Certification (current)

The programme is now in the certification phase. Small-wind certification is where the market’s credibility problem historically originated, and it is the gate XEVA needs to pass cleanly to differentiate the product from the rooftop wind category’s legacy reputation. The certification work is ongoing and specific details remain commercially confidential to Airplus.

The commercial move

The engineering conclusion that reshaped the product architecture is that on a building, siting — not the turbine itself — is the binding constraint on rooftop wind generation.

That reframes the product. XEVA is not “a rooftop wind turbine” but a rooftop wind system — turbine, tolerant intake geometry, repositionable mounting, onboard storage and smoothing — engineered against characterised building-flow physics rather than idealised free-stream conditions. The product positioning on the deliverable power profile (clean, buffered, retrofit-compatible, additive to existing solar and storage assets) follows from the engineering conclusion, not the other way round.

For a small-wind product heading into certification, that positioning matters commercially. It is the honest answer to the market’s legitimate scepticism about rooftop wind — not a marketing claim that the turbine works anywhere, but an engineered system designed for the specific flow regimes real buildings actually generate, with the mounting flexibility to tune siting empirically post-install.

What the engagement has produced to date

• A generator selection conforming to the base-model prototype specification.
• A baseline CFD model of the base-model turbine in characteristic building-flow conditions.
• Iterative CFD development across warehouse, multi-level commercial, and dense-urban rooftop typologies.
• Wind-tunnel validation of the prototype against the CFD predictions.
• A mounting-system engineering conclusion — post-install repositioning as a product requirement — that has shaped the product architecture.
• Current-phase engineering support on the certification pathway.

Why it matters

Rooftop wind has been a sceptical category for a decade — and for good reasons. Most products that reached market did so without the building-aerodynamics engineering depth the physics requires, and the category’s credibility has paid for that. The way back into the category’s credibility runs through CFD-anchored siting work, physical-test validation, certification, and product architectures that accept the unpredictability of real buildings rather than pretending it away. That is a longer, slower engineering programme than the first-generation entrants ran — and it is the programme the market needed them to run.

The broader point is that decentralised energy for high-dependency sites — hospitals, data centres, industrial facilities, coastal infrastructure — is a market in which the winning products will be those that deliver a reliable, buffered power profile, not raw generation; and that can be sited into the messy real-world environments their host sites actually present, not the idealised conditions a spec sheet describes. Getting to that product shape requires engineering partnership across the full arc from prototype to certification, and the willingness to let the engineering evidence shape the product architecture.

A note on status

The engagement is ongoing. Certification work is live. Specific technical performance data, siting methodology detail, and certification-pathway specifics remain commercially confidential to Airplus Renewables.

KYMA Battery Technologies — transatlantic company creation, founder-built and founder-exited

From an idea in 2022 to a certified demonstrator on utility test and a clean founder exit. KYMA was incorporated in Wisconsin, seed-funded, and operated transatlantically — engineering and commercial strategy from the UK, manufacturing and site presence in the US. The case establishes transatlantic company creation as a distinct Hatch Oxford capability.

The starting position

In 2022 the US grid storage market was accelerating into a supply-demand imbalance the battery industry could not close from new-cell production alone. Gigafactory build-out was underway but years from the installed capacity that policy demand signals required. At the same time, first-generation EV batteries were reaching the first wave of module-level failures, warranty replacements, and end-of-service events — a fast-growing volume of batteries which were in most cases being landfilled or sent for destructive recycling, even though the underlying power cells were often still functional. The binding failure was typically elsewhere in the powertrain or in pack-level control, not in the cells themselves.

The thesis was straightforward. Intake those modules. Sort and test them against a characterised acceptance specification. Repackage tested modules into grid-storage battery packs, chemistry-agnostic at pack level, with a battery management system engineered to operate heterogeneously across mixed module sources. Stand the product up against the demonstrator cascade US utilities expected — residential, commercial UPS, containerised grid — reach commercial certification, and enter the grid storage market with a unit-economics and embodied-carbon profile a new-cell competitor would struggle to match.

The harder question was not technical. It was operational. Neither founder was based in the US; the market, the capital, and the raw feedstock were. KYMA had to be incorporated, capitalised, sited, and built — credibly — from a transatlantic operating model.

What we built

The engagement is ourselves. Lesley Blaine and Chris Gregory co-founded KYMA Battery Technologies in August 2022, ran it together, and exited cleanly two years later.

August 2022 — Company formation and seed capitalisation

KYMA Battery Technologies was incorporated in the US and seed-funded. The corporate structure was deliberately set up as a three-entity configuration — an operating company for KYMA Battery Technologies, a separate entity for product sales, and a third for grid-storage asset ownership — separating IP and product revenue from capital-intensive asset-ownership plays. The choice was deliberate. It preserved the optionality to build, own, and operate grid-storage assets directly when the project economics justified it, without burdening the product business with asset-heavy balance-sheet characteristics.

2023 — Site, partners, first demonstrator

A 90-acre site was secured in Wisconsin, with on-site warehousing for battery assembly and repurposing and the capacity to serve as both manufacturing facility and first grid-storage asset. A 13,000 sq ft operational facility was stood up. Battery-handling permits were filed. Two-way tie-ins with the local utility were established. Relationships with local universities and the technical college created a viable talent pool. In parallel, the product partner network was built — residential design, product development, inverters, battery management, and a working design relationship for the containerised grid-storage products. In September 2023 the first 10 kW residential demonstrator using 100% repurposed modules went live.

2024 — Commercial UPS, megawatt grid demonstrator, certification

February 2024 delivered the 50 kW commercial UPS demonstrator. June 2024 put the first 1 MW containerised grid-storage system on test in Wisconsin with a regional utility trial partner. September 2024 closed the demonstrator arc with products certified for commercial use. The certification milestone was the gate. From that point KYMA had a product line — residential, commercial UPS, and grid-storage containerised systems at 250 kW, 500 kW, 1 MW, and 3 MW configurations — that could be sold into the US market rather than only demonstrated.

The transatlantic operating model

Throughout, KYMA was run across two geographies. Engineering leadership, commercial strategy, partnership development, and investor management were conducted from the UK. US operations, site development, regulatory engagement, hiring, and customer-facing delivery were conducted in Wisconsin. The model required deliberate architectural choices — a corporate structure that could absorb a transatlantic principal-and-operations split, contractual and governance arrangements that did not create timezone-triggered decision bottlenecks, and a deliberate separation of which decisions travelled and which stayed local. Those choices are the transferable lesson from the engagement.

Founder exit

Lesley and Chris exited KYMA cleanly two years after founding it, ahead of a subsequent change of control. The exit was executed without ongoing equity or operational involvement on either founder’s side. The product direction the company has taken under new ownership is its own narrative and is not described here.

The founding move

The move that distinguished KYMA from a conventional new-cell grid-storage venture was the decision to build the product around repurposed modules with a battery management system engineered for chemistry- and source-agnostic operation, rather than around new cells.

That decision set everything downstream. It determined the supply-chain architecture (module intake instead of cell procurement), the certification pathway (repurposed-module test and acceptance protocols rather than new-cell qualification), the demonstrator cascade (because repurposing-first products had to demonstrate against power profiles real utilities run, not just the test-bench profiles cell-level qualification produces), the embodied-carbon story (an order of magnitude lower than equivalent new-cell capacity), and the capital intensity of the business (the dominant cost was site, certification, and BMS engineering, not gigafactory CAPEX).

Repurposing-first was the original thesis. The demonstrator cascade reached certification on that thesis. The exit was clean on that thesis. Whether repurposing-first remains the right long-run answer for US grid storage is a question the market will keep settling for some time. What matters for this case is that the thesis was built, the company was built around it, the demonstrator cascade was completed, and the exit was cleanly executed.

What was built

• An incorporated US company with a three-entity corporate structure separating product and asset-ownership lines.
• Seed capital deployed against a two-to-three-year demonstrator roadmap.
• A 90-acre Wisconsin site with on-site warehousing, battery-handling permits, and utility tie-ins.
• A 13,000 sq ft operational facility stood up as both manufacturing base and demonstrator host.
• A partner network spanning residential design, product development, inverter supply, battery management, and containerised grid-storage design — each contracted into a modular product roadmap.
• A demonstrator cascade: 10 kW residential (September 2023), 50 kW commercial UPS (February 2024), 1 MW containerised grid on utility test (June 2024).
• Products certified for commercial use across residential, commercial UPS, and grid-storage containerised configurations from 250 kW to 3 MW (September 2024).
• A transatlantic operating model that sustained engineering leadership from the UK and operational presence in Wisconsin throughout.
• A clean founder exit executed ahead of the subsequent change of control.

Why it matters

Most founder stories in the deep-tech case-study literature are told as single-geography narratives — the UK venture, the US venture, the European venture. The reality for a non-trivial proportion of deep-tech founders is transatlantic. The capital is disproportionately in the US. The manufacturing scale and tax incentives increasingly are too. The engineering talent density is still distributed. And for founders who started their careers in UK research or UK industry, the right company is often one that is incorporated, capitalised, and operated in the US but led from where the founders already are.

That operating model is not automatic. It requires deliberate corporate-structure, governance, contracting, and decision-authority choices that most UK-centric venture-building playbooks do not describe and most US-centric ones do not either. Getting it right takes the kind of practical, lived familiarity with both sides that you only acquire by having actually built such a company.

KYMA is the case we point to when a founder asks how we think about transatlantic company creation. The specific thesis — repurposing-first US grid storage — is not the transferable lesson. The transferable lesson is operational: a UK-based founder team can incorporate, seed-fund, site, staff, partner, demonstrate, and certify a US deep-tech company inside roughly two years, and execute a clean exit without ever relocating the principal team. That is the operational claim. The evidence is the company.

A note on status

KYMA Battery Technologies was founded in August 2022 by Lesley Blaine and Chris Gregory, run by them through the demonstrator cascade and certification milestone, and exited cleanly ahead of a subsequent change of control. Lesley and Chris hold no ongoing equity or operational involvement in the company. This case study describes the founding-to-exit arc; it does not describe the company’s current operations under different ownership.

A retention decision for a university IP portfolio

A commercial viability assessment commissioned by a UK university enterprise office. Three patents from a single research group’s portfolio reframed as enabling IP for adoption by established commercial actors — not the basis for a new spinout.

The starting position

A UK university’s commercialisation office approached the engagement with a high-stakes triage question. Three interrelated patents from a single research group sat in the portfolio — technically credible, uncommitted commercially, and accruing annual prosecution costs. The TTO needed an evidence-based answer to a decision it had been deferring. Did these patents warrant retention and active commercial development, or should they be allowed to lapse?

The portfolio sat in a space familiar to any TTO managing IP from advanced engineering and applied science groups: the underlying science was well-established, but the practical adoption path remained unclear. Laboratory-scale feasibility was not the constraint. The constraints were specific to deployment, integration, and the commercial conditions under which industry would adopt.

The TTO did not need another technical review. The University’s own researchers knew science. What was missing was the commercial frame — a structured view of whether, where, and on what terms these patents could be commercialised.

What we did

The engagement was scoped and contracted as a paid commercial viability assessment. The work was anchored on a single decision: convert the portfolio’s assessed potential into an evidence-backed commercial recommendation, or recommend controlled wind-down.

The assessment deliberately resisted the trap of most IP reviews fall into — scoring patents against each other on abstract criteria. Instead, each patent was mapped to its natural point of adoption inside the eventual deployable system. Where it sits — at which architectural layer. What a partner would have to change to adopt it. What they would measure to confirm value. Which design-around routes would most plausibly influence claim strength.

That mapping translated into three connected outputs: a per-patent Competitiveness Matrix positioning each patent against its natural baseline; a per-patent Market Assessment naming primary adopter archetypes, buyer value drivers, acceptance criteria, and likely agreement form; and an Implementation Fit Matrix showing the specific change a partner would make to adopt each patent.

We ran the analysis against the field’s foundational and translational literature, so each patent could be assessed against documented commercialisation barriers rather than theoretical performance alone. The portfolio’s alignment with those documented barriers is what gave the retention case its evidential weight.

The commercial move

The most consequential decision in the assessment was the reframe from spinout to licensing.

The natural institutional reflex, faced with three credible patents, is to ask whether they could support a new spinout. That question has obvious appeal — spinouts are visible, fundable, celebrated — but in this case it was the wrong question.

The evidence pointed elsewhere. The three patents sat at different architectural layers of the eventual deployable system. Their combined commercial strength was as enabling IP for platforms being built by others, not as the technical core of a new standalone venture. None of the three, on its own profile, carried a new company. All of them carried a licence.

Two consequences follow from that reframe. The commercialisation work shifts from building a founder team and a funding round toward a defined, evidence-led engagement approach with prospective adopters. And the deal structure defaults away from blanket exclusivity, toward postures appropriate to the architectural layer at which each patent sits — broad adoption where breadth grows the addressable market; tighter scoping where architectural fit to a specific partner is what decides the deal.

For a university weighing prosecution spend against likelihood of return, the reframe matters. It is what separates a portfolio that accrues renewal costs indefinitely from one with a defined commercial form, defined adopter archetypes, and defined conditions under which effort should be narrowed.

What the engagement produced

• A retention recommendation — the portfolio justified continued prosecution and active commercialisation on a licensing basis, with a controlled narrowing rule if commercial traction did not materialise within a bounded period.
• A per-patent Competitiveness Matrix positioning each patent against its natural baseline, with differentiation strength and design-around risk quantified.
• A per-patent Market Assessment naming primary adopter archetypes, priority use cases, buyer value drivers, indicative acceptance criteria, procurement entry routes, and agreement form.
• An Implementation Fit Matrix translating each patent into the specific change a partner would make to adopt it and the evidence that would most plausibly trigger commercial terms.
• A licensing posture calibrated to the architectural layer at which each patent sits — designed to protect University value without granting exclusivity before technical fit is confirmed.
• A structural reasoning framework for engagement with the prospective adopter community, sufficient to guide University-led outreach while preserving confidentiality around specific counterparties.

Why it matters

Universities carry hundreds of patents through annual renewal cycles that nobody has time to re-evaluate. The institutional cost of that drift — in prosecution fees, in TTO bandwidth, in missed licensing windows — is rarely made visible, because nobody is paid to make the retention decision explicit. Most portfolio reviews either over-promise (every patent is a potential spinout) or under-promise (nothing here is commercial). Neither is honest, and neither produces a decision that can be acted on.

This engagement illustrates what an honest retention decision looks like when it is done with commercial rigour. The question was not “can these patents be sold” but “what is the commercial form this portfolio can credibly take, and what evidence would tell us whether that form works.” The answer was specific. Licensing, not spinout. Enabling IP, not foundational. A licensing posture calibrated to the architectural layer at which each patent sat.

That kind of retention work is easy to undervalue. It does not produce a headline event. It produces a decision a TTO can defend on evidence — to keep prosecuting, to narrow, or to let go. For a TTO managing a portfolio under pressure, which is worth more than another speculative spinout assessment.

A note on status

The engagement and its findings remain commercially confidential. This case study describes Hatch Oxford’s methodology at the level it can be discussed publicly. The client, the technology, the specific findings, and any counterparties are not identified.

Alpha 311 — engineering support across a prototype-to-production product generation

An engineering partnership at the point a seed-funded hardware venture graduates its design from validated prototype to production-ready product. The engagement produced the Mk.XII (Type 301) redesign through CFD and wind-tunnel work and structured the turbine for the DNV small-wind certification pathway.

The starting position

Alpha 311’s product thesis is a strong one. Large volumes of urban and roadside infrastructure — lighting columns in particular, along with building parapets and venue rooflines — host airflow regimes generated not just by meteorological wind but by the channelling, vehicle-wake, and building-induced flows that characterise the built environment. A retrofit vertical-axis turbine optimised for those flows, small enough to site on existing structures, with no requirement for planning-scale civils, addresses a decentralised-generation niche that neither utility-scale wind nor rooftop solar occupies.

The Mk.XI prototype had validated the concept end-to-end: the physics of harvesting urban airflow, the mechanical integration with existing host infrastructure, and the public-facing commercial appetite. Those validations had closed a funding round and attracted landmark deployment partners.

The natural next step for any hardware programme at that stage is the engineering transition from validated prototype to production-ready product. Production design tightens the aerodynamics against full CFD rather than first-principles estimate, moves manufacturability into the critical path, brings sub-systems under a single product breakdown structure for design and supplier governance, and begins the long-lead work of certification. Hatch Oxford was engaged to take that engineering transition forward.

What we did

The engagement ran as an engineering programme with specialist CFD and electrical design work commissioned through agreed sub-contractors. The work organised into two engineering streams, run in parallel.

Aerodynamic redesign through CFD and wind tunnel

The core engineering workstream took the turbine design into full computational fluid dynamics analysis and a parallel wind-tunnel programme. CFD modelling addressed the blade geometry, the rotor’s behaviour under the directionally-unstable flow fields that real urban installations produce — the flow over a lamppost, a bridge parapet, or a roadside barrier is not the free-stream flow a spec sheet assumes — and the interaction between the blade set and the surrounding support structure. Wind-tunnel testing was run in parallel to validate the CFD predictions against physical measurement and to generate the design-verification data required for certification.

The aerodynamic output of that work was the Mk.XII (Type 301) design: blade geometry and rotor assembly substantively reworked against CFD-and-tunnel evidence, with performance characterised across the operating envelope and the design-verification dataset captured for the certification pathway downstream.

Product breakdown structure and DNV certification pathway

In parallel, we structured the Mk.XII into a formal product breakdown covering four sub-systems: wind energy capture (blade and blade assembly, top and bottom plates, sleeve, bracketry, cowlings), control (turbine controller, sensor sets, electrical monitoring, consumer-unit control), electrical generation (alternator, bearings, grid-tie inverter, consumer unit, electrical enclosure), and safety (mechanical brake, electrical isolation, internal sensor set). Each component was assigned an ownership map — in-house, commercial-off-the-shelf, or specific sub-contractor — with supplier governance and single-point-of-failure risks identified for action.

On certification we brought forward a DNV small-wind pathway as the target. Four high-priority areas were scoped and actioned: the certification documentation expectation and the cost of plan-change for the electrical architecture, the test and verification plan (covering wind-tunnel verification, factory acceptance testing, and availability-reliability-maintainability), the electrical enclosure design (delivered through a specialist external design house), and the IT-and-software workshop required to lock the data-capture and sensor architecture in place before design freeze.

The engineering move

The engineering move that defines this engagement is the recognition that retrofit urban wind is a building-aerodynamics problem, not a turbine-design problem.

The flow over a lamppost, a bridge parapet, or a roadside barrier is not the free-stream flow that conventional wind-energy engineering designs against. It is directionally unstable, structurally interfered with, and unpredictable from first principles. Anchoring the rotor and blade redesign to characterised CFD flow fields — and then validating those fields against physical wind-tunnel measurement — is what gives the production turbine a defensible performance envelope. Without that anchor, a Mk.XII redesign is an aesthetic exercise. With it, the redesigned rotor is engineered against the flows it will actually see in service.

The product breakdown structure and the DNV pathway then carry that engineering work into manufacturability and certification — turning the validated aerodynamic design into a producible turbine that can be certified for the market it is heading into.

What the engagement produced

• A redesigned Mk.XII (Type 301) vertical-axis wind turbine, with blade geometry and rotor assembly re-engineered against CFD and wind-tunnel data.
• A full product breakdown structure across wind-capture, control, electrical-generation, and safety sub-systems, with supplier ownership mapped per component.
• A DNV small-wind certification pathway with four high-priority workstreams scoped and actioned — certification documentation, test and verification plan, electrical enclosure design, and the IT-and-software workshop required before design freeze.
• A sub-system supplier map identifying governance priorities across the electrical-enclosure design and the software and sensor architecture.
• A design-verification dataset, captured through the combined CFD-and-tunnel programme, suitable for downstream certification submission.

Why it matters

Retrofit urban wind is a category with genuine potential and specific technical demands. The flows around the built environment are different from the flows wind-energy engineering conventionally designs for. The products that succeed in the category will be those engineered against characterised urban-flow physics rather than free-stream assumptions. That requires CFD-and-tunnel-anchored aerodynamic design, a certification pathway scoped end-to-end, and a manufacturability discipline that takes the validated design into production rather than leaving it on the test bench.

Independent engineering partnership — delivered with enough technical specificity to take real production decisions against — is a high-leverage intervention at the point at which a seed-funded hardware venture graduates from prototype to production. The Mk.XII design, the certification pathway, and the product breakdown structure sit together as a coherent engineering programme.

A note on status

The engagement concluded in 2023. Alpha 311 Limited remains an active company. Specific engineering performance data, certification-pathway specifics, and commercial terms remain confidential to Alpha 311. The deliverables described in this case study are the engineering deliverables for which Hatch Oxford holds independent engagement records.

Market validation for a university power-electronics commercialisation pathway

A pre-commercialisation market study commissioned by a UK university research group to underpin a national innovation funding bid. Market sizing, end-user validation, value proposition development, and a realistic commercial route to market for a novel power-electronics technology aimed at the electricity distribution sector.

The starting position

A UK university research group approached the engagement with a high-stakes deadline. They had developed a novel power-electronics technology aimed at the electricity distribution sector and were preparing a bid for national innovation funding to take it from prototype toward commercial readiness. The funding programme required structured answers to two questions the research team did not yet have evidence to answer. What is the market opportunity? And what is the realistic route from research IP to commercial deployment?

A research group’s instinct, faced with that question, is to write the case the team believes to be true: large addressable market, clear gap in incumbent offerings, obvious value to end-users. That instinct is rarely wrong on the technology — but it is regularly wrong on the route. Funding panels read hundreds of technology-led optimism bids a year and discount them heavily. What earns funding is honest market evidence and a realistic commercialisation pathway, with the awkward findings included rather than smoothed over.

The research team was clear-eyed about this. They commissioned an external commercial assessment specifically because the bid would benefit from independent evidence rather than internal advocacy.

What we did

The engagement was scoped as a structured market study delivered against the funding bid timeline. The work was anchored on three connected questions: how large is the addressable market by voltage level, what do end-users and potential commercial partners actually want, and what is the realistic sequencing from prototype to commercial deployment.

Market sizing was done across two voltage segments. Low-voltage distribution is the high-volume end of the market — tens of thousands of units potentially deployable across a national network by 2050. Medium and high-voltage distribution is smaller in unit count but significantly higher in unit value, with hundreds of installations per country and individual assets in the multi-million-pound range. The two segments were sized separately because their commercial dynamics, procurement cycles, and adoption pathways are distinct.

End-user validation was approached as primary research. We designed a structured interview programme targeting distribution network operators, independent network operators, microgrid operators, and tier-one power-electronics manufacturers. We targeted ten to fifteen completed interviews to triangulate the assumptions in the technology’s value proposition.

What the outreach actually produced is the most useful single insight from the whole engagement. From over six hundred and fifty initial outreach contacts, we secured four complete interviews. The market does not engage with cold outreach. That finding — surfaced cleanly and reported honestly into the funding bid — is more commercially valuable than any individual interview would have been, because it changes the validation strategy any subsequent commercialisation work would adopt.

The four interviews and supporting desk research were sufficient to build a per-segment value proposition, rank the critical performance indices that decide procurement (cost per kVA, reliability and availability, footprint and weight, efficiency, power density, control and interoperability), identify both the technical and commercial risks, and structure a future development plan including the funding routes most aligned to the technology’s stage of readiness.

The commercial move

The most consequential commercial recommendation in the engagement was the reframe of the realistic route to market.

The technology-led case for the engagement is straightforward. The technology delivers measurable performance gains that align with documented end-user needs across the network operator and microgrid segments. The natural conclusion from a value-proposition exercise alone is that the addressable market is large and the technology should sell to it directly.

The market evidence pointed somewhere else.

End-users in this sector are uniformly conservative. They demand a high technology readiness level (TRL 7–9 minimum) before they will evaluate a new device. They expect twenty-plus year service life with minimal downtime. And they procure almost exclusively from existing tier-one supplier framework agreements that take three to five years for a new entrant to break into. Cold outreach into the procurement function does not work. New technology adoption goes through tier-one OEMs, because tier-one OEMs are the only entities the procurement systems are set up to buy from.

Two practical consequences follow for a university research group with a novel hardware technology.

The immediate commercial pathway runs through licensing or co-development with tier-one OEMs, not through direct sales to network operators. The research group’s commercialisation strategy needs to be a partnership strategy at its core — not a direct-sales strategy with partnership as a fallback.

And the lower-friction entry segment is low-voltage distribution coupled with renewable integration applications, where adoption cycles are faster and procurement is less locked into incumbent vendor frameworks. That gives the technology somewhere to demonstrate field performance on commercially meaningful timescales while the longer tier-one partnership work runs in parallel.

For a research group writing a funding bid, that reframe matters practically. It is what separates a bid that proposes “build the technology and sell to network operators” — which the funding panel will not believe — from a bid that proposes “build the technology, demonstrate on low-voltage renewable applications, and licence to a tier-one partner for higher-voltage commercial-scale deployment” — which the funding panel can defend.

What the engagement produced

• A market sizing analysis across both voltage segments, with addressable unit counts and per-unit values mapped by deployment timeline.
• A market driver analysis covering decarbonisation and electrification, distributed generation growth, ageing distribution infrastructure, and policy and regulatory incentives.
• A primary research programme — structured interviews with network operators, independent operators, microgrid operators, and tier-one OEMs — with the difficult finding that cold outreach into this market does not work.
• A per-segment value proposition naming target customer profile, pain points addressed, and quantified solution fit for each adopter type.
• A critical performance index analysis ranking what end-users actually weigh in procurement: cost, reliability and availability, footprint and weight, efficiency, power density, and control interoperability.
• A technical and commercial risk register with mitigation framing for each — including reliability under reconfiguration, integration with legacy systems, certification barriers, procurement lock-in with tier-one vendors, and competitive fast-following risk.
• A future development plan with sequenced funding routes (national innovation programmes, EU programmes, US programmes) and a recommended commercial pathway leading with low-voltage renewable applications and tier-one partnership for higher-voltage variants.

Why it matters

Universities sit on a great deal of credible engineering IP that never reaches the market. The reason is rarely that the technology does not work. The reason is that the commercialisation pathway is rarely written with commercial discipline — and funding bodies, partners, and licensees can spot the difference between aspirational case-making and evidence-based commercial reasoning at a glance.

The work this engagement produced is the kind of work that converts research IP into a commercial proposition funding panels can defend. Honest market sizing. Primary research that includes the awkward findings. A realistic route to market that respects how the procurement systems in the target sector actually work. A funding bid built on that evidence has a materially better chance of being funded — and, if funded, a materially better chance of producing technology that actually reaches deployment.

The unusual insight from this engagement — that the market does not respond to cold outreach, and that any subsequent validation work needs to route through tier-one OEM relationships, conferences, and standards bodies — is the kind of finding that re-shapes the next two years of commercialisation activity for any research team that takes it seriously.

For a research group preparing a funding bid, that kind of evidence-led commercial framing is worth more than another optimistic market overview.

A note on status

The engagement and its findings remain commercially confidential. This case study describes Hatch Oxford’s methodology at the level it can be discussed publicly. The client, the technology, the funding programme, the specific findings, and any counterparties are not identified.